No, This Approach Is Incorrect
Patients with chronic migraine should NOT be treated with Botox (onabotulinumtoxinA) alone without any other medication—they require both preventive therapy (which may include Botox) AND acute/abortive medications to treat individual migraine attacks when they occur. 1
Why Dual Treatment Is Essential
The Two-Pronged Treatment Framework
Chronic migraine management requires addressing two distinct clinical needs:
1. Preventive/Prophylactic Treatment (reduces frequency and severity of attacks)
- OnabotulinumtoxinA is FDA-approved specifically for chronic migraine prevention 1
- It is the ONLY FDA-approved therapy specifically indicated for chronic migraine prophylaxis 1
- Reduces headache days, migraine episodes, and cumulative headache hours 2, 3
2. Acute/Abortive Treatment (treats attacks when they occur)
- Even with excellent preventive therapy, breakthrough migraines will occur
- Patients need rescue medications for these episodes 4
Every chronic migraine treatment plan should include both prophylactic treatment AND as-needed treatment of exacerbations 1. This is not optional—it is a fundamental principle of migraine management.
Recommended Acute Medications to Combine with Botox
Even patients on Botox prophylaxis need acute treatments:
First-Line Acute Options:
- NSAIDs: Aspirin, ibuprofen, naproxen sodium 4
- Combination therapy: Aspirin-acetaminophen-caffeine 5
- Triptans: Sumatriptan, rizatriptan, zolmitriptan, eletriptan 5
- CGRP antagonists: Rimegepant, ubrogepant 5
Critical Caveat About Medication Overuse
Acute therapy should be limited to no more than twice per week to prevent medication-overuse headache 4. This is why preventive therapy like Botox is so important—it reduces the need for frequent acute medication use.
When to Use Botox for Chronic Migraine
Indications for Preventive Therapy (Including Botox):
- ≥15 headache days per month for at least 3 months 1, 6
- Two or more attacks per month producing disability lasting ≥3 days 4
- Contraindication to or failure of acute treatments 4
- Use of abortive medication more than twice per week 4
Evidence for Botox Efficacy:
The 2024 VA/DoD guidelines suggest onabotulinumtoxinA for chronic migraine prevention (weak recommendation) 5. The 2015 Mayo Clinic guidelines note it is the only FDA-approved therapy for chronic migraine prophylaxis 1. The PREEMPT trials demonstrated significant reductions in headache days (-8.4 vs -6.6 for placebo at 24 weeks, p<0.001) 3.
Important Distinction:
Botox should NOT be used for episodic migraine (<15 headache days/month). The 2024 guidelines recommend AGAINST botulinum toxin for episodic migraine 5, and the 2017 AAN guidelines state it was ineffective and should not be offered 6. The 2025 PRECLUDE trial confirmed this, showing no significant benefit over placebo in episodic migraine 7.
Proper Treatment Sequencing
Before Starting Botox:
Patients should preferably have tried 2-3 other migraine prophylactics first 8. First-line preventive agents include:
- Propranolol (80-240 mg/d)
- Timolol (20-30 mg/d)
- Amitriptyline (30-150 mg/d)
- Divalproex sodium (500-1500 mg/d)
- Topiramate 4, 1
Medication Overuse Consideration:
If medication overuse is present (73% of chronic migraine patients) 1, patients should ideally be withdrawn from overused medications before starting Botox. However, if withdrawal is not feasible, Botox can be initiated concurrently 8.
Common Pitfall to Avoid
The most dangerous misconception is that preventive therapy alone is sufficient. Even patients with excellent response to Botox (≥50% reduction in headache days) will still experience breakthrough migraines requiring acute treatment. Withholding acute medications leaves patients suffering unnecessarily during these episodes and contradicts evidence-based guidelines 1.
The correct approach: Botox for prevention + appropriate acute medications for breakthrough attacks, with careful monitoring to avoid medication overuse.